Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in XENON PHARMACEUTICALS INC
DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.5M shares of XENE (XENON PHARMACEUTICALS INC), worth $203.4M as of 2025-Q4. The position was increased (++8.9% shares). XENE represents 1.4% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$203.4M
Current Shares
4.5M
Total Value Change
+$31.1M
Total Shares Change
+119,219
Other major holders of XENE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 4.5M |
+8.9% |
| $203.4M |
| 1.4% |
| $44.12 |
53 |
| 2025-Q3 | Decreased | 4.2M | -3.8% | $167.4M | 1.2% | $39.06 | 0 |
| 2025-Q2 | Decreased | 4.3M | -5.4% | $135.7M | 1.1% | $32.40 | 0 |
| 2025-Q1 | Increased | 4.6M | +1.4% | $153.8M | 1.5% | $34.26 | 48 |
| 2024-Q4 | Decreased | 4.5M | -1.6% | $177.2M | 1.5% | $38.53 | 0 |
| 2024-Q3 | Increased | 4.6M | +4.0% | $180.9M | 1.6% | $38.65 | 50 |
| 2024-Q2 | Increased | 4.4M | +2.3% | $172.3M | 1.7% | $38.99 | 49 |